Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers

  • Suárez Calvet, Marc|||0000-0002-2993-569X
  • Kleinberger, Gernot|||0000-0002-5811-8226
  • Araque Caballero, Miguel Ángel
  • Brendel, Matthias|||0000-0002-9247-2843
  • Rominger, Axel
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Blesa, Rafael|||0000-0003-4026-2884
  • Gispert, Juan Domingo|||0000-0002-6155-0642
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Antonell, Anna|||0000-0002-3286-8459
  • Rami Gonzalez, Lorena|||0000-0002-7411-1921
  • Molinuevo, José Luis|||0000-0003-0485-6001
  • Brosseron, Frederic
  • Traschütz, Andreas
  • Heneka, Michael|||0000-0003-4996-1630
  • Struyfs, Hanne
  • Engelborghs, Sebastiaan|||0000-0003-0304-9785
  • Sleegers, Kristel|||0000-0002-0283-2332
  • Van Broeckhoven, Christine|||0000-0003-0183-7665
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Nellgård, Bengt
  • Blennow, Kaj|||0000-0002-1890-4193
  • Crispin, Alexander
  • Ewers, Michael|||0000-0001-5231-1714
  • Haass, Christian|||0000-0002-4869-1627
2 is an innate immune receptor expressed on the surface of microglia. Loss-of-function mutations of 2 are associated with increased risk of Alzheimer's disease (). 2 is a type-1 protein with an ectodomain that is proteolytically cleaved and released into the extracellular space as a soluble variant (2), which can be measured in the cerebrospinal fluid (). In this cross-sectional multicenter study, we investigated whether levels of 2 are changed during the clinical course of , and in cognitively normal individuals with suspected non- pathology (). 2 levels were higher in mild cognitive impairment due to than in all other groups and controls. individuals also had significantly increased 2 compared to controls. Moreover, increased 2 levels were associated with higher total tau and phospho-tau, which are markers of neuronal degeneration and tau pathology. Our data demonstrate that 2 levels are increased in the early symptomatic phase of , probably reflecting a corresponding change of the microglia activation status in response to neuronal degeneration.